February 05, 2009
Novo Nordisk AS and Sciele Pharma Inc. announced on Wednesday the launch of a type 2 diabetes combination drug. PrandiMet combines Novo Nordisk's Prandin (repaglinide) with the generic drug metformin.
Warc anticipates global adspend growth this year to ring in at a healthy 4.7%, or $572bn (£410bn).
Brands should refrain from tweets that are over 100 characters, according to Twitter's director of brand strategy.